What is lung cancer?
Lung cancer is a tumour or mass formed by abnormal cells in the lungs, airways (bronchi) or windpipe (trachea). Cancer that starts in the lungs is called primary lung cancer, whereas cancer that starts somewhere else and then spreads to the lungs is called secondary lung cancer or lung metastases.
With 49,000 new cases every year, lung cancer is the third most common cancer in the UK, according to Cancer Research UK. Almost half (45%) of new lung cancer cases are in people over 75.
More people pass away from lung cancer than any other type of cancer. This is why detecting lung cancer at the earliest stages is very important.
Lung cancer early symptoms and signs
Lung cancer does not always cause symptoms, especially in the early stages. But diagnosing the disease early gives the best outcomes, so see a doctor quickly if ever you notice symptoms.
Signs of lung cancer include:
- A cough lasting more than three weeks
- Chest infections or pains
- Breathlessness
- Fatigue
- A hoarse voice
- Blood in your phlegm or mucus
- Loss of appetite
- Unexplained weight loss
Having one or more of these symptoms doesn’t always mean you have lung cancer, as other conditions can cause them too. But lung symptoms always need to be checked by a doctor and you may still need treatment to help your symptoms, regardless of the cause.
If you're concerned about lung cancer, see your GP as soon as possible who may arrange for you to have some tests to help decide if you need to see a specialist such as a pulmonologist.
Types of lung cancer
Non-small cell lung cancer
The most common type of lung cancer is non-small cell lung cancer (NSCLC), which includes two main subtypes of cancer named after the cells they affect:
- Adenocarcinoma, which starts in the gland cells that make mucus in your lungs
- Squamous cell cancer, which starts in the cells that cover the airways
Depending on the stage, NSCLC can be treated with surgery or radiotherapy, which may be given with chemotherapy or immunotherapy.
You’re more likely to have EGFR mutation positive lung cancer if you:
- Have adenocarcinoma
- Are a woman
- Have never smoked or are light smokers
Small-cell lung cancer
Small-cell lung cancer gets its name because the appear much smaller when viewed under a microscope by a pathologist. It’s a less common type of lung cancer.
Small-cell lung cancer is usually not treated with surgery unless it’s found at a very early stage. Your treatment plan may combine chemotherapy, radiotherapy, or immunotherapy.
What causes lung cancer?
Smoking isn’t the only cause of lung cancer, and 1 in 5 people with lung cancer have never smoked.
Some types of lung cancer are more common in people who have never smoked. EGFR mutation positive lung cancer is a subtype that mainly affects women and never smokers, and accounts for around 10 to 15% of all lung cancers.
Other factors that increase your risk include exposure to certain chemicals and pollution and a family history of lung cancer.
Lung cancer diagnosis and tests
How is lung cancer diagnosed?
Lung cancer is commonly diagnosed after seeing a consultant for symptoms like a long-lasting cough or breathlessness.
The first step to diagnosis is to have imaging scans, including chest X-rays, CT scans, and PET-CT scans. If these show evidence of a possible cancer, such as a mass or tumour in the lungs, then a biopsy is needed to diagnose lung cancer.
Stages of lung cancer
Lung cancer staging describes how far the cancer has spread, which is used to decide the best possible treatment plan.
Non-small cell lung cancer has four possible stages:
- Stage one – the cancer is small, and hasn’t spread outside the lungs
- Stage two – also called early-stage, when there are one or more tumours in the same lung and/or nearby lymph nodes
- Stage three – also called locally advanced, where the cancer has spread to nearby tissues or lymph nodes
- Stage four – also called advanced or metastatic, where the cancer has spread outside the lungs
It is possible to cure non-small cell lung cancer when it is stage I-III. The care of patients with stage IV lung cancer is more focused on treating and managing the cancer.
There are only two stages to describe small-cell lung cancer:
- Limited disease, meaning the cancer is only in one lung, may have spread to nearby lymph nodes and can be treated with radiotherapy
- Extensive disease, meaning the cancer is in both lungs and may have spread to far away lymph nodes or other organs
Limited stage small cell lung cancer can be cured in some patients. The care of patients with extensive stage small cell lung cancer is more focused on treating and managing the cancer.
Lung cancer treatment overview
How is lung cancer treated?
The main treatments for lung cancer include:
- Surgery – mainly used for early-stage NSCLC (stage I-III), surgery aims to remove as much disease as possible and is often the first step for treating early or locally advanced lung cancer
- Radiotherapy – a non-invasive treatment that uses high doses of radiation to kill cancer cells, radiotherapy can be a curative treatment in patients with early stage NSCLC (stage I-III) and limited stage small-cell lung cancer. Stereotactic ablative radiotherapy (SABR) can be used as a curative treatment for patients with very early stage NSCLC (stage I-II) or as a way of controlling the cancer or helping with symptoms in patients with more advanced cancer (stage 4).
- Chemotherapy – This may be given before, during or after surgery or radiotherapy to increase the chances of curing the cancer. For people with advanced NSCLC (stage IV) this may be their main treatment for their lung cancer but may also be given in combination with immunotherapy or targeted therapy. This treatment is usually given as an infusion through a vein.
- Immunotherapy – There are immunotherapies available for lung cancer, which aim to increase the immune system’s natural response to cancer cells to help destroy them. This may be recommended before surgery, after surgery, following radiotherapy or as a treatment for patients with advanced NSCLC (stage IV). Sometimes immunotherapy is given in combination with chemotherapy. This treatment is usually given as an infusion through a vein.
- Targeted Therapy – Targeted drug therapies, often given in tablet form are, are given to patients who have a cancer that contain specific mutations in certain genes. EGFR mutation positive lung cancer is the most common type of cancer treated with a targeted drug therapy but there are many others rarer types.
Learn more about treatments for other types of lung-related cancer:
Lung cancer risk factors
Risk factors can increase your chances of developing lung cancer.
These include:
- Older age – 45% are diagnosed over 75
- Smoking - including second-hand smoke
- Exposure to chemicals – including radon, asbestos and air pollution
- A family history of lung cancer
- Certain medical conditions affecting the lungs
Anyone can get lung cancer, even without risk factors. Always see a doctor if you have symptoms.
Lung cancer complications
Lung cancer is a serious disease, and both the condition and its treatment can cause complications. Patients with lung cancer need continuous support to reduce complications and improve recovery for the best possible outcomes.
At GenesisCare, you’ll be under the care of a team of experts, including consultant oncologists and surgeons. They will create a custom care plan based on your diagnosis and preferences, starting treatment within days if needed. Every patient is supported through their journey with life-changing therapies, such as exercise medicine and psychological support.
Prevention of lung cancer
Most cases of lung cancer are linked to smoking, which includes second-hand smoke. Quitting smoking reduces your risk of lung cancer and improves your health at any age, no matter how long you’ve smoked. Quitting smoking can also help reduce the possible side effects from treatment.
Lung cancer treatment at GenesisCare
We are the UKs leading provider of specialist private cancer care. By choosing us, you can be reassured that your lung cancer treatment will be managed by a team of specialists working together with you to decide the best personalised care plan for your diagnosis.
Our approach to world-class care for lung cancer includes:
- A personalised plan built around you
- Treatment starting within days if needed
- 14 outpatient cancer centres across the UK
- State-of-the-art facilities specialising in advanced radiotherapy
- Compassionate chemotherapy nurses available 24/7 by telephone
- Integrative cancer care including wellbeing therapies and exercise medicine
- We'll help you with transport depending on treatment and locations, when required
- Recognised by all leading private medical insurers with self-pay options available
We’re proud that so many patients rate our care as excellent as we help them through their cancer journey. Find out more about the unique experiences of people who have had their cancer diagnosis or treatment at GenesisCare in our patient stories section.
Our consultants have close relationships with expert surgeons from local and nationally renowned hospitals. They work together with other cancer specialists to decide the best course of treatment for you. If your consultant recommends lung cancer surgery, we can arrange it at one of our convenient partner hospitals. You can then continue your other treatments at GenesisCare.
There are various procedures for lung cancer surgery, for example, a lobectomy to remove the part of your lung containing the cancer. Your surgeon will recommend the most appropriate technique depending on the size and stage of your tumour.
Radiotherapy uses targeted, high-energy radiation beams to destroy cancer cells. It’s often a preferred treatment option for patients with non-small cell lung cancer that isn’t suitable for surgery. It can also be combined with chemotherapy (chemoradiation) or after surgery to remove any leftover cancer tissue.
At GenesisCare we are the leading private provider of radiotherapy in the UK. We offer world-class expertise, state-of-the-art facilities and advanced radiotherapy techniques. Our latest-generation radiotherapy machines (called linacs) deliver highly targeted radiation beams, designed to be effective while minimising the radiation dose to healthy tissues.
Your radiotherapy treatment for lung cancer is overseen by our expert multidisciplinary teams (MDTs), consisting of oncologists, radiotherapists and medical physicists. They work together to make sure you receive only the best possible care.
We offer:
Volumetric modulated arc therapy (VMAT), which helps limit side effects by targeting radiation to cancer cells while avoiding healthy cells. Together with image-guided radiotherapy, it precisely targets areas of cancer, adjusting the beam and intensity to allow for movement, when breathing for example.
4DCT is a computed tomography (CT) scan that assesses how much your lung tumour moves when you breathe. This helps guide specialist breathing techniques, such as deep inspiration breath hold that reduces tumour movement during treatment to help ensure the radiotherapy is accurately targeted.
Deep inspiration breath hold (DIBH) is a technique to help control movements due to breathing and minimise any radiation delivered to healthy tissues during treatment.
Stereotactic ablative radiotherapy (SABR) is an advanced radiotherapy technique that uses very focused, high-energy radiation beams to remove tumours in five or fewer sessions. It’s often used instead of surgery or in patients with advanced cancer can be used to keep the cancer under control for longer or help with symptoms.
MRIdian is a new type of machine which delivers SABR using live images to target the tumour highly accurately and protect healthy tissues. GenesisCare is the first UK provider offering this treatment, and lung cancer patients from all over the country can be referred to our centres in Oxford and Cromwell.
The MRIdan can also be used to deliver SABR reirradiation (repeat SABR) to treat lung cancer that has previously been treated with radiotherapy and has since returned.
Find out more about MRIdian for lung cancer.
We also offer palliative VMAT radiotherapy for those living with advanced lung cancer, where it has spread elsewhere in the body, to improve pain and increase mobility. We understand that fast access to palliative care is paramount and can usually provide treatment within 48 hours of a planning imaging scan.
We offer all types of drug therapies used to treat and manage pancreatic cancer, including many of the newest treatments. Depending on the treatment, you may attend one of our private suites staffed by our specialist nurses.
Our compassionate nursing teams are available 24/7 on a dedicated on-call telephone service and can answer any queries during your treatment. They’ll be able to provide advice about side effects or symptoms and arrange any care you need throughout.
Our centres have all been awarded the Macmillan Quality Environment Mark for the quality care we offer to cancer patients.
There are different types of drug treatments, also called systemic anti-cancer therapies. Our expert teams continually review and assess new treatments to make these available to GenesisCare patients as early as possible.
Chemotherapy
Chemotherapy treatment for lung cancer can be delivered on its own, before or after surgery, or in combination with other treatments including radiotherapy (chemoradiation) and immunotherapy.
Targeted therapy
Targeted therapies (also called biological therapies) are a specialised group of drugs that have been designed to attack or block certain processes in cancer cells that tumours depend on to survive and grow.
Immunotherapy
Immunotherapies work by helping your body’s immune system to recognise and fight the cancer.
Palliative care
If your cancer has spread to other parts of the body, it’s called advanced or metastatic lung cancer. At GenesisCare, you can receive palliative drug treatment for advanced lung cancer, to reduce the size and progress of your cancer and ease any symptoms.
Personalised medicine
For some advanced cancers, we use specialist tests, such as liquid biopsy or genomic testing, to understand the genetic makeup of cancer cells. This helps find which drugs can work against specific cancer mutations, so we can begin effective treatment without delay.
There may also be opportunities to access clinical trials for the newest treatments for lung cancer.
Side effects
No treatment is without side effects. Your doctor will explain these to you depending on your drug treatment, together with the ways your treatment plan and supporting care can help to manage or minimise these.
At GenesisCare, we do more than just treat your cancer. As part of our unique and integrative approach to cancer care, you can expect the best possible care and a personalised treatment plan that also includes access to life-changing therapies which are proven to improve cancer-related outcomes.
These therapies will be tailored to you to help you manage and cope with your cancer as well as the specific side effects of treatment.
Exercise medicine
Exercise medicine is a personalised programme of carefully planned and supported physical activity has been shown to improve outcomes for cancer patients, by enhancing their quality of life and limiting the impact of cancer, such as by improving strength and reducing fatigue.
One of our physiotherapists specialising in exercise for people living with cancer will provide a 12-week programme tailored to you supported by our dedicated GenesisCare Exercise Medicine app. They’ll work closely with you to monitor changes in your health and support you throughout the programme to help you get the best results.
Wellbeing
We also offer a wellbeing expert and holistic therapies such as counselling, acupuncture, massage and reflexology through our unique partnership with the Penny Brohn UK charity. This service is available to all lung cancer patients at any of our 14 UK centres.
FAQs about lung cancer
Vapes are an alternative to cigarettes, but whether they carry a risk of cancer is still unclear. They’re a relatively new product and more long-term studies are needed to understand how vaping affects your risk of lung cancer.
However, what we know already is that many vapes contain chemicals known to cause cancer, including:
- Benzene
- Heavy metals
- Volatile organic compounds
Long-term studies will reveal whether vaping has a lower risk of lung cancer compared to smoking. Vaping may increase your risk of lung cancer compared to not vaping or smoking at all. However, vaping can be a helpful way to support people as they quit smoking.
If you’re having symptoms of lung cancer, a chest X-ray is usually the first step to investigating the cause. A chest X-ray creates images inside your lungs and can show abnormal structures or masses.
It’s not possible to tell from an X-ray whether a growth is caused by lung cancer or something else, like a lung abscess. If something unusual shows up on your chest X-ray, a biopsy is needed to find out if it’s lung cancer.
The UK has launched a free lung cancer screening program called the ‘Lung Health Check’ (LHC). Most people over the age of 55 who have previously smoked or who are current smokers are eligible. In this programme a CT scan of the chest is performed. Please contact your GP for more information. Many of our partner hospitals offer lung screening programmes.
Lung cancer has better outcomes when it’s diagnosed at stage 1, which is when it’s only in one lung and hasn’t spread to distant parts of the body.
The majority of patients diagnosed with stage 1 lung cancer will live for 5 years or more after their diagnosis.
There are treatments available for lung cancer at all stages, which range from intensive treatments to palliative care.
Lung cancer that has spread outside the lungs is called stage 4 lung cancer, advanced lung cancer, or metastatic lung cancer.
The most common places for lung cancer to spread are:
- Lymph nodes
- Other parts of the lung or the other lung
- The brain
- The bones
- The liver
- The adrenal glands
To learn more about lung cancer watch this short video from MacMillan with Dr Ranj and Dr David Gilligan, Clinical Oncologist at GenesisCare.
Reviewed by: Professor Crispin Hiley
Clinical Director for lung cancer at GenesisCare
October 2024